drugset / Trial / NCT03324815

Methadone Associated With Morphine for Cancer Pain

NCT03324815

Unknown 40 enrolled Federal University of São Paulo
RandomizedParallel-groupSingle-blindTreatment

Summary

The study was prospective, randomized. Patients with cancer pain were evaluated, one group receiving methadone with morphine and another group receiving morphine as the only opioid. Pain intensity, total morphine dose and adverse effects were evaluated.

Timeline

Start
2017-03-02
Primary completion
2018-07-30
Completion
2018-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methadone Other / unclassified 2.5 mg
Comparator Morphine Other / unclassified 5 mg

Indications